![](/wp-content/uploads/2023/02/Screenshot-2023-02-28-at-3.25.42-PM.png)
$599
Bayer Q4 ’22 Earnings Update
Bayer hosted its Q4 ’22 earnings call (press release; slides) and provided updates across its business, including Kerendia (finerenone) in the context of the ongoing US launch and LCM initiatives. Below, FENIX provides highlights and insights from the call.